Short Bowel Syndrome
📧 Sign up to get email alerts when something new happens for Short Bowel Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2018-03-22Clinical Trial Update: SMOFLipid in Patients Who Are Intralipid Intolerant [Phase 4]
A Phase 4 clinical trial evaluating SMOFLipid in patients intolerant to Intralipid for home parenteral nutrition or short bowel syndrome has…
-
CLINICAL_TRIALS withdrawal · 2017-06-22Clinical Trial Update: Investigational Study of Oral Fish Oil in Treating Parenteral Nutrition Associated Liver Disease [Phase 1, Phase 2]
The Phase 1/2 trial evaluating oral fish oil for parenteral nutrition-associated liver disease sponsored by Boston Children's Hospital has b…
-
CLINICAL_TRIALS withdrawal · 2017-06-22Clinical Trial Update: Trial of 70% Ethanol Versus Heparin to Reduce the Rate of Central Line Infections in Children With Short Bowel Syndrome [Phase 2]
A Phase 2 trial comparing 70% ethanol to heparin to reduce central-line infections in children with Short Bowel Syndrome has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-02-18Clinical Trial Update: A Open Label Extension Study for Subjects That Complete Study MP-101-CL-001 [Phase 3]
The Phase 3 open-label extension MP-101-CL-001 for short bowel syndrome has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-02-18Clinical Trial Update: A Phase III Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Investigational Product MP-101 in Subjects With Short Bowel Syndrome Who Have Had an Inadequate Response to Anti-Diarrheals [Phase 3]
Phase III trial of MP-101 for short bowel syndrome has been withdrawn due to inadequate response to anti-diarrheals.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2014-01-15Clinical Trial Update: Fiber Use in Pediatric Short Bowel Syndrome [NA]
Clinical trial investigating fiber use in pediatric Short Bowel Syndrome has been withdrawn (NCT00922805).
-
CLINICAL_TRIALS withdrawal · 2014-01-14Clinical Trial Update: Exenatide on GI Motor Function and Permeability in Short Bowel Syndrome [Phase 4]
A Phase 4 clinical trial evaluating Exenatide for gastrointestinal motor function and permeability in Short Bowel Syndrome has been withdraw…